| JKN454
|
Research Grade Casirivimab
|
2415933-42-3 |
95% |
None
|
| JKN453
|
Research Grade Camidanlumab
|
921618-45-3 |
95% |
None
|
| JKN452
|
Research Grade Bersanlimab
|
1987854-08-9 |
95% |
None
|
| JKN451
|
Research Grade Bemarituzumab
|
1952272-74-0 |
95% |
None
|
| JKN450
|
Research Grade Avizakimab
|
2229685-51-0 |
95% |
None
|
| JKN449
|
Research Grade Atidortoxumab
|
1939108-95-8 |
95% |
None
|
| JKN448
|
Research Grade Apamistamab
|
2097132-02-8 |
95% |
None
|
| JKN447
|
Research Grade Afelimomab
|
156227-98-4 |
95% |
None
|
| JKN446
|
阿泽奇单抗
|
2043952-59-4 |
95% |
|
| JKN445
|
壬托鲁单抗
|
1791410-27-9 |
95% |
|
鄂公网安备42011102005485号
鄂ICP备2024034540号
? 2023万利官网
